Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead the Next Phase of Innovation-Driven Growth

Contributed by: Business Wire

Logo

Tags

Biotechnology

Health

Science

Pharmaceutical

Research

Chiesi Group

More Like This

Maria Paola Chiesi is appointed Chair of Chiesi Board of Directors, the first woman in this role; aims to reinforce sustainability as an integral and enduring pillar of the Group’s strategy

Chiesi Group Announces New Chair and Vice Chair

Chiesi Reports Strong FY2025 Financial and Sustainability Results and Announces Leadership Transition Highlights

Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities

Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices

PR Newswire associated0

CordenPharma Appoints Dr. Jean-Luc Herbeaux as Chief Executive Officer to Lead Next Phase of Growth

Chiesi Group's new Biotech Center of Excellence brings the future of medicine to Parma

Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges

Stefan Doboczky, Chief Executive Officer of Hovione. Photo credit: Karl Michalski.

Hovione Appoints Stefan Doboczky as Chief Executive Officer